Global Breast Cancer Liquid Biopsy Market Professional Survey Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Breast Cancer Liquid Biopsy Revenue
• 1.4 Market by Type
  • 1.4.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Circulating Tumor Cells (CTCs)
  • 1.4.3 Cell-Free DNA (CfDNA)
  • 1.4.4 Extracellular Vesicles (EVs)
  • 1.4.5 Other Circulating Biomarkers
• 1.5 Market by Application
  • 1.5.1 Global Breast Cancer Liquid Biopsy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Diagnostic Centers
  • 1.5.4 Laboratories
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Breast Cancer Liquid Biopsy Market Perspective (2015-2026)
• 2.2 Global Breast Cancer Liquid Biopsy Growth Trends by Regions
  • 2.2.1 Breast Cancer Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Breast Cancer Liquid Biopsy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Breast Cancer Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Breast Cancer Liquid Biopsy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Breast Cancer Liquid Biopsy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Breast Cancer Liquid Biopsy Players by Market Size
  • 3.1.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue (2015-2020)
  • 3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Breast Cancer Liquid Biopsy Market Concentration Ratio
  • 3.2.1 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Liquid Biopsy Revenue in 2019
• 3.3 Breast Cancer Liquid Biopsy Key Players Head office and Area Served
• 3.4 Key Players Breast Cancer Liquid Biopsy Product Solution and Service
• 3.5 Date of Enter into Breast Cancer Liquid Biopsy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Type (2015-2020)
• 4.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
• 5.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Breast Cancer Liquid Biopsy Market Size (2015-2020)
• 6.2 Breast Cancer Liquid Biopsy Key Players in North America (2019-2020)
• 6.3 North America Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 6.4 North America Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Breast Cancer Liquid Biopsy Market Size (2015-2020)
• 7.2 Breast Cancer Liquid Biopsy Key Players in Europe (2019-2020)
• 7.3 Europe Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 7.4 Europe Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

8 China

• 8.1 China Breast Cancer Liquid Biopsy Market Size (2015-2020)
• 8.2 Breast Cancer Liquid Biopsy Key Players in China (2019-2020)
• 8.3 China Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 8.4 China Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Breast Cancer Liquid Biopsy Market Size (2015-2020)
• 9.2 Breast Cancer Liquid Biopsy Key Players in Japan (2019-2020)
• 9.3 Japan Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 9.4 Japan Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Breast Cancer Liquid Biopsy Market Size (2015-2020)
• 10.2 Breast Cancer Liquid Biopsy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

11 India

• 11.1 India Breast Cancer Liquid Biopsy Market Size (2015-2020)
• 11.2 Breast Cancer Liquid Biopsy Key Players in India (2019-2020)
• 11.3 India Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 11.4 India Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Breast Cancer Liquid Biopsy Market Size (2015-2020)
• 12.2 Breast Cancer Liquid Biopsy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 12.4 Central & South America Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 QIAGEN
  • 13.1.1 QIAGEN Company Details
  • 13.1.2 QIAGEN Business Overview
  • 13.1.3 QIAGEN Breast Cancer Liquid Biopsy Introduction
  • 13.1.4 QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2015-2020))
  • 13.1.5 QIAGEN Recent Development
• 13.2 Roche Diagnostics
  • 13.2.1 Roche Diagnostics Company Details
  • 13.2.2 Roche Diagnostics Business Overview
  • 13.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Introduction
  • 13.2.4 Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 13.2.5 Roche Diagnostics Recent Development
• 13.3 Bio-Rad Laboratories
  • 13.3.1 Bio-Rad Laboratories Company Details
  • 13.3.2 Bio-Rad Laboratories Business Overview
  • 13.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Introduction
  • 13.3.4 Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 13.3.5 Bio-Rad Laboratories Recent Development
• 13.4 Myriad Genetics
  • 13.4.1 Myriad Genetics Company Details
  • 13.4.2 Myriad Genetics Business Overview
  • 13.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Introduction
  • 13.4.4 Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 13.4.5 Myriad Genetics Recent Development
• 13.5 Menarini Silicon Biosystems
  • 13.5.1 Menarini Silicon Biosystems Company Details
  • 13.5.2 Menarini Silicon Biosystems Business Overview
  • 13.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Introduction
  • 13.5.4 Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 13.5.5 Menarini Silicon Biosystems Recent Development
• 13.6 Genomic Health
  • 13.6.1 Genomic Health Company Details
  • 13.6.2 Genomic Health Business Overview
  • 13.6.3 Genomic Health Breast Cancer Liquid Biopsy Introduction
  • 13.6.4 Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 13.6.5 Genomic Health Recent Development
• 13.7 Thermo Fisher Scientific
  • 13.7.1 Thermo Fisher Scientific Company Details
  • 13.7.2 Thermo Fisher Scientific Business Overview
  • 13.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Introduction
  • 13.7.4 Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 13.7.5 Thermo Fisher Scientific Recent Development
• 13.8 Illumina
  • 13.8.1 Illumina Company Details
  • 13.8.2 Illumina Business Overview
  • 13.8.3 Illumina Breast Cancer Liquid Biopsy Introduction
  • 13.8.4 Illumina Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 13.8.5 Illumina Recent Development
• 13.9 Biocept
  • 13.9.1 Biocept Company Details
  • 13.9.2 Biocept Business Overview
  • 13.9.3 Biocept Breast Cancer Liquid Biopsy Introduction
  • 13.9.4 Biocept Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 13.9.5 Biocept Recent Development
• 13.10 Trovagene
  • 13.10.1 Trovagene Company Details
  • 13.10.2 Trovagene Business Overview
  • 13.10.3 Trovagene Breast Cancer Liquid Biopsy Introduction
  • 13.10.4 Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 13.10.5 Trovagene Recent Development
• 13.11 Guardant Health
  • 10.11.1 Guardant Health Company Details
  • 10.11.2 Guardant Health Business Overview
  • 10.11.3 Guardant Health Breast Cancer Liquid Biopsy Introduction
  • 10.11.4 Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 10.11.5 Guardant Health Recent Development
• 13.12 RainDance Technologies
  • 10.12.1 RainDance Technologies Company Details
  • 10.12.2 RainDance Technologies Business Overview
  • 10.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Introduction
  • 10.12.4 RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 10.12.5 RainDance Technologies Recent Development
• 13.13 MDx Health
  • 10.13.1 MDx Health Company Details
  • 10.13.2 MDx Health Business Overview
  • 10.13.3 MDx Health Breast Cancer Liquid Biopsy Introduction
  • 10.13.4 MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
  • 10.13.5 MDx Health Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer